Invention Application
WO99024024A3 TREATMENT OF T-HELPER CELL TYPE 2 MEDIATED IMMUNE DISEASES WITH RETINOID ANTAGONISTS
审中-公开
T细胞类型2介导的免疫反应性免疫缺陷病毒治疗
- Patent Title: TREATMENT OF T-HELPER CELL TYPE 2 MEDIATED IMMUNE DISEASES WITH RETINOID ANTAGONISTS
- Patent Title (English): Treatment of t-helper cell type 2 mediated immune diseases with retinoid antagonists
- Patent Title (中): T细胞类型2介导的免疫反应性免疫缺陷病毒治疗
-
Application No.: PCT/EP1998/007067Application Date: 1998-11-05
-
Publication No.: WO99024024A3Publication Date: 1999-08-19
- Main IPC: A61K9/06
- IPC: A61K9/06 ; A61K9/08 ; A61K9/107 ; A61K9/12 ; A61K9/14 ; A61K9/20 ; A61K9/48 ; A61K9/72 ; A61K31/166 ; A61K31/19 ; A61K31/192 ; A61K31/195 ; A61K31/196 ; A61K31/20 ; A61K31/201 ; A61K31/202 ; A61K31/216 ; A61K31/35 ; A61K31/352 ; A61K31/353 ; A61K31/38 ; A61K31/382 ; A61K31/385 ; A61K31/407 ; A61K31/415 ; A61K31/4162 ; A61K31/4184 ; A61K31/44 ; A61K31/4439 ; A61K31/55 ; A61K31/551 ; A61K31/5513 ; A61K45/00 ; A61P11/00 ; A61P11/02 ; A61P11/06 ; A61P17/00 ; A61P27/16 ; A61P29/00 ; A61P37/00 ; A61P37/06 ; A61P37/08 ; A61P43/00 ; C07C57/42 ; C07C57/48 ; C07D235/02 ; C07D243/38 ; C07D311/58 ; C07D335/06 ; C07D339/02 ; C07D401/06 ; C07D495/04
Abstract:
Retinoids with retinoid receptor antagonistic activity called retinoid antagonists, pharmaceutically acceptable salts and pharmaceutically acceptable hydrolyzable esters thereof, have been found to be efficacious in the treatment of T-helper cell type 2 (Th2)-mediated immune diseases, such as immunoglobulin E (IgE)-mediated allergic diseases.
Information query
